Ascom Acquires the Italian Medical Software Company UMS

AscomAscom has acquired the Italian software company UMS (United Medical Software), which provides integrations for medical devices and supplies digital medical records software solutions for life-critical patient care. With the acquisition of UMS, Ascom will gain access to new software and competence for global integrated workflow solutions in Healthcare ICT. Moreover, Ascom will improve its market position in Italy significantly thanks to the UMS installed base.

UMS s.r.l. is a privately held medical software company based in the region of Florence. The company delivers modular, point-of-care, digital medical records software solutions for life-critical patient care. UMS solutions help clinicians treat patients facing life-critical outcomes, while filing the gaps in digital medical records technology. UMS offers more than 200 medical device integrations and 1,000 different EMR forms and integrations. UMS' customers include large university hospitals, private specialty clinics, and healthcare government entities. UMS has products ready for international deployment and installations in Europe. The Company produces CE-marked medical device software, and is a partner/supplier of large companies in the medical device business.

UMS has a well-established installed base, mainly in the Italian market, and is expected to achieve revenues in the range of EUR 3-4 million in 2015, with EBITDA margins comparable to the Ascom Wireless Solutions Division.

With this acquisition, Ascom will gain access to new software and additional competence for global integrated workflow solutions in Healthcare ICT. Ascom will leverage the acquired software solutions globally. Consequently, capabilities to integrate medical devices and therefore mission-critical data into existing Ascom workflow solutions and Ascom Myco will be increased. In addition, Ascom will be granted access to new solutions for intensive care and surgical workflow management in high acuity units. Finally, the acquisition will help Ascom reach previously underserved geographical areas and increase its market share in Italy and Southern Europe. The acquisition fits perfectly with Ascom’s strategy for achieving its 2020 ambitions.

Ascom signed an agreement to acquire all shares of the company UMS s.r.l. Closing is expected to take place in mid-January 2016. All 27 employees will be taken over at their existing location. The purchase price amounts to the mid-single digit millions in CHF. In addition, Ascom has agreed to an earn-out payment in the low-single digit millions in CHF, dependent on the achievement of agreed revenue targets.

Gabriele Unterberger, who founded and successfully led UMS, will continue to run the company, to be renamed "Ascom UMS s.r.l.", as its Managing Director.

"Ascom is very pleased to have acquired a business with such a good strategic fit. This is an important technology acquisition for Ascom’s Healthcare ICT strategy. With the acquired software solutions, we have the opportunity to give our customers even more possibilities to improve their clinical workflows. In addition, we will gain direct access to the Italian market. This transaction accelerates Ascom’s roadmap for its integration capabilities and is the next step in building and strengthening the leading position of Wireless Solutions in the global healthcare communications market," underlines Claes Ödman, General Manager Ascom Wireless Solutions.

About Ascom
Ascom is an international solutions provider with comprehensive know-how in healthcare workflows and telecommunications. The company is active in Wireless Solutions (an international market leader for high-value, customer-specific on-site communication solutions and workflow optimization) and Network Testing (a global market leader in testing, monitoring, post processing, and performance optimization for mobile networks). The Ascom Group is headquartered in Switzerland, has subsidiaries in 19 countries and employs around 1,700 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...